Outpost Medicine
Biopharma, Biotechnology, Medical, Pharmaceutical
Founded in 2016-01-01
Indianapolis, Indiana, United States
For Profit
About Outpost Medicine
At Outpost, they are committed to developing novel therapeutics for the treatment of gastrointestinal and urologic disorders. The company's lead clinical-stage product candidate is in development for the treatment of overactive bladder (OAB) and irritable bowel syndrome (IBS).
Company Metrics
- Employees: 11-50
- Monthly Visits: None
- Tech Stack: 7 active products
Financial Information
- Estimated Revenue: $1M to $10M
- Total Funding: 61000000 USD
- Last Funding: 20000000 USD (Series A)
- Funding Status: Early Stage Venture
Technology Stack
Outpost Medicine actively uses 7 products in their tech stack.
Market Presence
Industries: Biopharma, Biotechnology, Medical, Pharmaceutical
Headquarters: Indianapolis, Indiana, United States